# Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer

> **NCT00073385** · PHASE2 · COMPLETED · sponsor: **Titan Pharmaceuticals** · enrollment: 225 (—)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Pivanex
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT00073385
- **Lead sponsor:** Titan Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 225 (—)
- **Last updated:** 2005-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00073385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00073385, "Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00073385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*